All In MedTech

Device Trial Radar · NCT02878629

Mandibular Advancement Devices Tali® in Patients With Syndrome of Obstructive Sleep Apnea and Hypopneas

Last checked: Nov 19, 2026Latest source record: Aug 28, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

254

Actual

Start

Jul 2016

Primary completion

Aug 2019

Study completion Aug 2019

Sponsor

Lead sponsor
ONIRISNot on our public-company list
Sponsor type
Industry
First posted
Aug 25, 2016

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main objective is to evaluate middle term compliance (≥ 2 years) of the Mandibular Advancement Devices Tali® in patients with Syndrome of Obstructive Sleep Apnea and Hypopneas.

Conditions

  • Syndrome of Obstructive Sleep Apnea and Hypopneas

Interventions

  • Mandibular Advancement DevicesDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. compliance (no stop of the Mandibular Advancement Device)Time frame: 2 years or more after the beginning of device

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Liberal cabinet

    Paris, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.